1208 related articles for article (PubMed ID: 8677737)
41. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.
Brugger W; Bross K; Frisch J; Dern P; Weber B; Mertelsmann R; Kanz L
Blood; 1992 Mar; 79(5):1193-200. PubMed ID: 1371415
[TBL] [Abstract][Full Text] [Related]
42. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
[TBL] [Abstract][Full Text] [Related]
43. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells.
Tong J; Gordon MS; Srour EF; Cooper RJ; Orazi A; McNiece I; Hoffman R
Blood; 1993 Aug; 82(3):784-91. PubMed ID: 7687893
[TBL] [Abstract][Full Text] [Related]
44. Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures.
Johnsen HE; Jensen L; Gaarsdal E; Hansen PB; Ersbøll J; Hansen NE
Exp Hematol; 1994 Jan; 22(1):80-6. PubMed ID: 7506675
[TBL] [Abstract][Full Text] [Related]
45. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
[TBL] [Abstract][Full Text] [Related]
46. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer.
Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J
J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969
[TBL] [Abstract][Full Text] [Related]
47. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
Cairo MS; Plunkett JM; Schendel P; van de Ven C
Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
[TBL] [Abstract][Full Text] [Related]
48. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
49. Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells.
Caux C; Moreau I; Saeland S; Banchereau J
Blood; 1992 May; 79(10):2628-35. PubMed ID: 1375107
[TBL] [Abstract][Full Text] [Related]
50. Ex-vivo expansion of CFU-GM and BFU-E in unselected PBMC cultures with Flt3L is enhanced by autologous plasma.
Guo M; Miller WM; Papoutsakis ET; Patel S; James C; Goolsby C; Winter JN
Cytotherapy; 1999; 1(3):183-94. PubMed ID: 12881174
[TBL] [Abstract][Full Text] [Related]
51. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
52. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
53. Effects of recombinant human interleukin-3 on human hematopoietic progenitor and precursor cells in vivo.
Ottmann OG; Ganser A; Seipelt G; Eder M; Schulz G; Hoelzer D
Blood; 1990 Oct; 76(8):1494-502. PubMed ID: 2207325
[TBL] [Abstract][Full Text] [Related]
54. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor.
Johnsen HE; Hansen PB; Plesner T; Jensen L; Gaarsdal E; Andersen H; Hansen SW; Birgens H; Jacobsen GK; Kjaersgaard E
Bone Marrow Transplant; 1992 Sep; 10(3):229-34. PubMed ID: 1384899
[TBL] [Abstract][Full Text] [Related]
55. Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Dai CH; Krantz SB; Dessypris EN; Means RT; Horn ST; Gilbert HS
Blood; 1992 Aug; 80(4):891-9. PubMed ID: 1498332
[TBL] [Abstract][Full Text] [Related]
56. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
[TBL] [Abstract][Full Text] [Related]
57. A phase I trial of interleukin 3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy.
Sosman JA; Stiff PJ; Bayer RA; Peliska J; Peace DJ; Loutfi S; Stock W; Oldenburg D; Unverzagt K; Bender J
Bone Marrow Transplant; 1995 Nov; 16(5):655-61. PubMed ID: 8547862
[TBL] [Abstract][Full Text] [Related]
58. Suppressive effects of TNF-alpha, TGF-beta1, and chemokines on megakaryocytic colony formation in CD34+ cells derived from umbilical cord blood compared with mobilized peripheral blood and bone marrow.
Lu L; Wang LS; Cooper RJ; Liu HJ; Turner K; Weich N; Broxmeyer HE
J Hematother Stem Cell Res; 2000 Apr; 9(2):195-204. PubMed ID: 10813532
[TBL] [Abstract][Full Text] [Related]
59. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
60. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
